Navigation Links
Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
Date:9/14/2007

consisted of $5.1 million of royalty fees earned from the commercial sales of memantine by Merz and its marketing partners in the United States and certain European countries, $3.2 million from the sale of NTI's rights and assets related to XERECEPT to Celtic, and $4.0 million from the reimbursement of the direct expenses incurred for the services provided to Celtic.

Research and development expenses of $26.7 million in the year ended June 30, 2007 increased by $3.9 million compared to R&D expenses of $22.8 million in fiscal year 2006. During fiscal year 2007, $21.2 million of the R&D expenses were focused on Viprinex(TM), with the remaining $5.5 million on XERECEPT. The increase in research and development expenses resulted from an additional $5.2 million of expenses incurred for the Phase 3 clinical trials of Viprinex, which was partially offset by a decrease of $1.3 million of reimbursed expenses for the continuing Phase 3 clinical trials for XERECEPT.

The Company had no acquired in-process research and development expenses for the fiscal year ended June 30, 2007 compared to $11.5 million for the fiscal year ended June 30, 2006. The 2006 expenses represented the expensing of certain tangible and intangible assets related to the acquisition of Empire Pharmaceuticals from 2005.

General and administrative expenses totaled $6.5 million for the year ended June 30, 2007 compared to $6.0 million in fiscal year 2006. The increase in general and administrative expenses resulted primarily from increases of approximately $362,000 for compensation, $259,000 for consultants and $276,000 for audit fees, offset by a $243,000 decrease in legal fees.

Investment income for the fiscal year ended June 30, 2007 totaled approximately $494,000 compared to $399,000 in fiscal year 2006. The increase was due to higher average cash balances in fiscal 2007 and an increase in our average rate of return on our investment portfolio.

Gain on change in value of warr
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 RXi Pharmaceuticals ... on discovering and developing innovative therapeutics, primarily in the ... of a public offering of 26 million units at ... for gross proceeds of approximately $10.4 million. Each unit ... a 13-month overallotment purchase right to purchase 0.50 of ...
(Date:5/28/2015)... 28, 2015  GenVec, Inc. (Nasdaq: GNVC ) ... J. Swirsky , will present a company overview at ... EDT on Thursday, June 4, 2015. ... will be available at the following link:  http://wsw.com/webcast/jeff88/gnvc ... website.  To access, visit www.genvec.com , click on ...
(Date:5/28/2015)... The Fertility Centers of New England ... Vitiello has taken on a new and expanded role ... provide guidance, leadership, oversight and quality assurance for the ... among our team of experienced reproductive endocrinologists,” said Fertility ... Hill, M.D. “Her expertise and compassionate, individualized care have ...
(Date:5/28/2015)... 2015 Whitehouse Laboratories is excited to ... term partnership with PTI Inspection Systems. Whitehouse Labs and ... with custom-tailored method development and validation programs using ... The agreement includes a more formal program that facilitates ... lines. This enables a more effective team approach, especially ...
Breaking Biology Technology:RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3GenVec To Present At The Jefferies Healthcare Conference 2Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2Whitehouse Labs Renews & Enhances Partnership with PTI Inspection Systems 2Whitehouse Labs Renews & Enhances Partnership with PTI Inspection Systems 3
... plant-derived insulin program, scheduled to enter the ... SBS, CALGARY, July 29 /PRNewswire-FirstCall/ - SemBioSys ... of therapeutic,proteins for metabolic and cardiovascular diseases, today ... (IND) application for,safflower-produced recombinant human insulin to the ...
... American College of Chest Physicians (ACCP) Guidelines Will Increase ... Use of Trellis(R) Peripheral Infusion ... College of Chest,Physicians (ACCP) has published new evidence-based clinical ... use of pharmacomechanical,thrombolysis for acute iliofemoral deep vein thrombosis ...
... Washington, DC State and local officials have taken ... nanomaterials, a major step for a cutting-edge technology that ... , On July 28, the Cambridge (Mass.) Public ... take several steps to gain a better understanding of ...
Cached Biology Technology:SemBioSys submits IND for safflower-produced insulin to U.S. FDA 2SemBioSys submits IND for safflower-produced insulin to U.S. FDA 3Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT 2Local officials move toward monitoring nanotechnologies 2Local officials move toward monitoring nanotechnologies 3
(Date:5/28/2015)... , May 28, 2015 Industry analyst ... a new report titled "Markets for Self-Healing Materials: ... inorganic capsule and vascular systems, biomaterials, relevant shape ... to around $2.7 billion by 2020. ... extensive coverage of smart materials. Other recent n-tech reports ...
(Date:5/27/2015)... 27, 2015   Codonics (codonics.com), ... and image documentation solutions and Omnicell ... automation solutions, is pleased to announce their ... Safe Label System® (SLS), an award-winning FDA ... the Omnicell Anesthesia Workstation, helps prevent medication ...
(Date:5/26/2015)... Research and Markets ( ... "Saudi Arabia Biometric Systems Market Forecast and ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... to grow at over 22% CAGR through 2020 ... the surging demand for better biometric technologies in ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2
... A new study investigating the respiratory system of insects ... for decades: why insects routinely stop breathing for minutes ... UC Irvine and Humboldt University propose that insects such ... beetles and bugs close off their respiratory systems periodically ...
... a stunning example of evolution at work, scientists have now ... changes in the skeletal armor of fish living in the ... 2005, issue of journal Science, bring new data to long-standing ... motivation is to try to understand how new animal types ...
... accustomed to nesting on islands free of predators began ... in the Aleutian archipelago in the 18th century. The ... study published this week in the journal Science now ... through entire island ecosystems, transforming the vegetation from lush ...
Cached Biology News:Why do insects stop 'breathing'? To avoid damage from too much oxygen, say researchers 2Why do insects stop 'breathing'? To avoid damage from too much oxygen, say researchers 3Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 2Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 3Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 4Octopuses occasionally stroll around on two arms, UC Berkeley biologists report 5Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 2Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 3Introduced foxes transformed vegetation on Aleutian Islands from lush grasslands to tundra 4
Rabbit polyclonal to Staphylococcus Enterotoxin A (HRP) ( Abpromise for all tested applications)....
... SigmaStat 3.5 is a user-friendly statistical ... allows them to perform statistical analysis without ... questions about your data and research and ... your data against the tests underlying assumptions ...
... Novexin offers bespoke, cost-effective solutions for complex protein ... extensive expertise and experience to help you develop a ... , , ... , transfer all methodology ...
... ChemiLucent™ Plus is a chemiluminescent ... used independently to boost the signal ... blot detection kits. ChemiLucent™ Plus is ... technology. Unlike conjugated complex- or chemiluminescent ...
Biology Products: